Cigna’s Cure Risks Dangerous Side Effects
The $52 billion purchase of Express Scripts likely increases risks instead of lowering them
Major deals in the health-care supply chain may be better news for sellers than for buyers.
Health-insurance giant Cigna announced Thursday morning that it plans to buy the pharmacy-benefit manager Express Scripts Holding for about $52 billion in cash and stock. Cigna shares dove sharply Thursday morning, and for good reason.
Granted, Cigna’s...
![[https://m.wsj.net/video/20180307/030718facebookad2/030718facebookad2_167x94.jpg]](https://m.wsj.net/video/20180307/030718facebookad2/030718facebookad2_167x94.jpg)
![[https://m.wsj.net/video/20180307/03082018rusprotest/03082018rusprotest_167x94.jpg]](https://m.wsj.net/video/20180307/03082018rusprotest/03082018rusprotest_167x94.jpg)
![[https://m.wsj.net/video/20180307/030718galaxys9_2/030718galaxys9_2_167x94.jpg]](https://m.wsj.net/video/20180307/030718galaxys9_2/030718galaxys9_2_167x94.jpg)
![[https://m.wsj.net/video/20180304/030518workingsmarter2/030518workingsmarter2_167x94.jpg]](https://m.wsj.net/video/20180304/030518workingsmarter2/030518workingsmarter2_167x94.jpg)
![[https://m.wsj.net/video/20180306/030718rusdata/030718rusdata_167x94.jpg]](https://m.wsj.net/video/20180306/030718rusdata/030718rusdata_167x94.jpg)
